Morgan Stanley’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
6,450,933
+2,432,559
| +61% | +$4.18M | ﹤0.01% | 3341 |
|
|
2025
Q1 | $13.4M | Buy |
4,018,374
+58,535
| +1% | +$195K | ﹤0.01% | 3079 |
|
|
2024
Q4 | $29.3M | Buy |
3,959,839
+1,811,265
| +84% | +$13.4M | ﹤0.01% | 2367 |
|
|
2024
Q3 | $20.2M | Sell |
2,148,574
-674,289
| -24% | -$6.33M | ﹤0.01% | 2797 |
|
|
2024
Q2 | $22.6M | Buy |
2,822,863
+131,842
| +5% | +$1.06M | ﹤0.01% | 2516 |
|
|
2024
Q1 | $39.9M | Sell |
2,691,021
-4,740,069
| -64% | -$70.2M | ﹤0.01% | 1963 |
|
|
2023
Q4 | $60.4M | Buy |
7,431,090
+4,948,965
| +199% | +$40.2M | ﹤0.01% | 2237 |
|
|
2023
Q3 | $11.3M | Sell |
2,482,125
-1,015,483
| -29% | -$4.62M | ﹤0.01% | 3012 |
|
|
2023
Q2 | $24.6M | Sell |
3,497,608
-4,195,083
| -55% | -$29.5M | ﹤0.01% | 2264 |
|
|
2023
Q1 | $47M | Buy |
7,692,691
+2,722,822
| +55% | +$16.6M | 0.01% | 1590 |
|
|
2022
Q4 | $31.8M | Buy |
4,969,869
+3,921,869
| +374% | +$25.1M | ﹤0.01% | 1907 |
|
|
2022
Q3 | $10M | Sell |
1,048,000
-402,057
| -28% | -$3.85M | ﹤0.01% | 2982 |
|
|
2022
Q2 | $16M | Buy |
1,450,057
+891,307
| +160% | +$9.84M | ﹤0.01% | 2525 |
|
|
2022
Q1 | $9.3M | Buy |
558,750
+305,175
| +120% | +$5.08M | ﹤0.01% | 2980 |
|
|
2021
Q4 | $4.84M | Sell |
253,575
-65,284
| -20% | -$1.25M | ﹤0.01% | 3759 |
|
|
2021
Q3 | $7.86M | Buy |
318,859
+79,262
| +33% | +$1.95M | ﹤0.01% | 3185 |
|
|
2021
Q2 | $6.24M | Sell |
239,597
-313,717
| -57% | -$8.16M | ﹤0.01% | 3548 |
|
|
2021
Q1 | $17.5M | Buy |
553,314
+363,661
| +192% | +$11.5M | ﹤0.01% | 2051 |
|
|
2020
Q4 | $8.8M | Buy |
189,653
+81,368
| +75% | +$3.78M | ﹤0.01% | 2655 |
|
|
2020
Q3 | $3.57M | Sell |
108,285
-45,697
| -30% | -$1.5M | ﹤0.01% | 3057 |
|
|
2020
Q2 | $4.23M | Buy |
153,982
+53,124
| +53% | +$1.46M | ﹤0.01% | 2846 |
|
|
2020
Q1 | $3.02M | Sell |
100,858
-88,072
| -47% | -$2.64M | ﹤0.01% | 2960 |
|
|
2019
Q4 | $5.23M | Sell |
188,930
-104,637
| -36% | -$2.9M | ﹤0.01% | 3160 |
|
|
2019
Q3 | $5.34M | Buy |
293,567
+256,249
| +687% | +$4.66M | ﹤0.01% | 2806 |
|
|
2019
Q2 | $915K | Sell |
37,318
-54,190
| -59% | -$1.33M | ﹤0.01% | 4267 |
|
|
2019
Q1 | $870K | Sell |
91,508
-133,365
| -59% | -$1.27M | ﹤0.01% | 4209 |
|
|
2018
Q4 | $1.99M | Buy |
224,873
+74,781
| +50% | +$662K | ﹤0.01% | 3775 |
|
|
2018
Q3 | $1.69M | Sell |
150,092
-117,863
| -44% | -$1.33M | ﹤0.01% | 4147 |
|
|
2018
Q2 | $3.43M | Buy |
267,955
+107,996
| +68% | +$1.38M | ﹤0.01% | 3578 |
|
|
2018
Q1 | $2.7M | Buy |
159,959
+33,277
| +26% | +$562K | ﹤0.01% | 3687 |
|
|
2017
Q4 | $1.01M | Buy |
126,682
+40,807
| +48% | +$326K | ﹤0.01% | 4528 |
|
|
2017
Q3 | $666K | Buy |
85,875
+35,173
| +69% | +$273K | ﹤0.01% | 4697 |
|
|
2017
Q2 | $373K | Sell |
50,702
-32,986
| -39% | -$243K | ﹤0.01% | 4984 |
|
|
2017
Q1 | $624K | Sell |
83,688
-92,925
| -53% | -$693K | ﹤0.01% | 4693 |
|
|
2016
Q4 | $1.23M | Buy |
176,613
+148,279
| +523% | +$1.03M | ﹤0.01% | 4311 |
|
|
2016
Q3 | $234K | Sell |
28,334
-28,647
| -50% | -$237K | ﹤0.01% | 4946 |
|
|
2016
Q2 | $462K | Sell |
56,981
-9,055
| -14% | -$73.4K | ﹤0.01% | 4472 |
|
|
2016
Q1 | $336K | Buy |
66,036
+3,455
| +6% | +$17.6K | ﹤0.01% | 4660 |
|
|
2015
Q4 | $483K | Buy |
62,581
+21,248
| +51% | +$164K | ﹤0.01% | 4570 |
|
|
2015
Q3 | $238K | Buy |
41,333
+27,414
| +197% | +$158K | ﹤0.01% | 5001 |
|
|
2015
Q2 | $128K | Buy |
13,919
+410
| +3% | +$3.77K | ﹤0.01% | 5460 |
|
|
2015
Q1 | $164K | Buy |
+13,509
| New | +$164K | ﹤0.01% | 5298 |
|